Clomiphene and anti-oestrogens for ovulation induction in PCOS, Cochrane Database Syst Rev, vol.4, p.2249, 2009. ,
Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS : a prospective randomized trial, Eur J Obstet Gynecol Reprod Biol, vol.159, pp.151-155, 2011. ,
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies, J Natl Cancer Inst, vol.88, pp.1810-1830, 1996. ,
Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer, Hum Pathol, vol.30, pp.151-158, 1999. ,
Comparison of prophylactic oophorectomy specimens from carriers and non carriers of a BRCA1 or BRCA2 gene mutation, J Natl Cancer Inst, vol.91, pp.626-634, 1999. ,
Morphologic precursors of ovarian epithelial tumors, Obstet Gynecol, vol.82, pp.181-187, 1993. ,
Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma, Gynecol Oncol, vol.38, pp.67-72, 1990. ,
Controlateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions, Int J Gynecol Patho, vol.12, pp.59-63, 1993. ,
Histological features of the controlateral ovary in patients with unilateral ovarian cancer: a case control study, Gynecol Oncol, vol.71, pp.437-478, 1998. ,
Surgical implications of the potential new tubal pathway for the ovarian carcinogenesis, J Minim Invasive Gynecol, vol.20, pp.153-162, 2013. ,
,
, European Journal of Histochemistry, vol.58, p.2251, 2014.
, Atypical epithelial proliferation in Fallopian tubes in prophylactic salpingooophorectomy specimens from BRCA 1 and BRCA 2 germline mutation carriers
, Int J Gynecol Pathol, vol.23, pp.35-40, 2003.
Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity, Gynecol Oncol, vol.82, pp.344-353, 2001. ,
Ovarian epithelial dysplasia after ovulation induction: time and dose effect, Human Reprod, vol.24, pp.132-140, 2009. ,
about serous ovarian carcinogenesis, Crit Rev Oncol Hematol, vol.88, pp.134-177, 2013. ,
Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme, Ann Pathol, vol.31, pp.3-10, 2011. ,
Don't forget fallopian tubes! A morphologic and immunohistochemical study about Fallopian tubes with genetic risk ,
, Gynecol Obstet Fertil, vol.40, pp.14-22, 2012.
Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential?, Int J Gynecol Pathol, vol.14, pp.107-120, 1995. ,
Dysplastic changes in prophylactic removed fallopian tubes of women predisposed to developping ovarian cancer, J Pathol, vol.195, pp.451-457, 2001. ,
Prophylactic oophorectomy, Cancer, vol.98, pp.2599-606, 2003. ,
ALDH1 expression correlates with favorable prognosis in ovarian cancers, Modern Pathol, vol.22, pp.817-840, 2009. ,
Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations, Cancer, vol.86, pp.1544-50, 1999. ,
Induction of ovulation and ovarian cancer: a critical review of the literature, Fertil Steril, vol.85, pp.819-845, 2006. ,
The effects of ovulation induction on ovarian epithelium dysplasia scores and Ki67 expression: an experimental study on rats, Int J Gynecol cancer, vol.15, pp.866-71, 2005. ,
Effects of ovulation induction on ovarian morphology: an animal study, Int J Gynecol Cancer, vol.14, pp.600-606, 2004. ,
Effects of ovulation induction agents on ovarian surface epithelium in rats, Reprod Biomed Online, vol.19, pp.314-332, 2009. ,
Tuboovarian dysplasia in relatioship with ovulation in rats, Fertil Steril, vol.99, pp.1768-73, 2013. ,
The effect of tamoxifen and raloxifen on estrogen metabolism and endometrial cancer risk, J Steroid Mol Biol, vol.126, pp.78-86, 2011. ,
Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment, Eur J Gynaecol Oncol, vol.30, pp.357-60, 2009. ,
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers, Gynecol Oncol, vol.115, pp.135-142, 2009. ,
Ovarian cancer risk in premenopausal and perimenaopausal women treated with Tamoxifen: a case-control study, Br J Cancer, vol.96, pp.850-855, 2007. ,
Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen, Gynecol Oncol, vol.60, pp.54-62, 1996. ,
Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reports, Int J Gynecol Cancer, vol.19, pp.1521-1524, 2009. ,
Bilateral atypical hyperplasia of the fallopian tube associated with tamoxifen : a report of two cases, Int J Gynecol Pathol, vol.17, pp.284-289, 1999. ,
Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen, Carcinogenesis, vol.18, pp.2009-2023, 1997. ,
Tamoxifen prevents premalignant changes of breast, but not ovarian cancer in rats at high risk for both diseases, Cancer Prev Res, vol.1, pp.546-53, 2008. ,
Morphological and immunohistochemical analysis in ovaries and tubes of tamoxifen, letrozole and clomifene-treated rats, Arch Gynecol Obstet, 2014. ,
A candidate precursor to pelvic serous cancer (p53 signature) and their prevalence in ovaries and fallopian tubes from women with BRCA mutations, Gynecol oncol, vol.109, pp.168-73, 2008. ,
Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer, Clin Med Res, vol.5, pp.35-44, 2007. ,
Riskreducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy, J Clin Oncol, vol.23, pp.127-159, 2005. ,
Clinical and pathologic findings of prophylactic salpingooophorectomies in 159 BRCA1 and BRCA2 carriers, Gynecol Oncol, vol.100, pp.58-64, 2006. ,
Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma, Annu Rev Pathol, vol.9, pp.27-45, 2014. ,
Hormonal interactions in endometrial cancer, Endoc Relat Cancer, vol.7, pp.227-269, 2000. ,
Ovarian cancer: emerging concept on cancer stem cells, J Ov Research, vol.4, pp.1-9, 2008. ,
BRCA1 regulates human mammary stem/progenitor cell fate, Proc Natl Acad Sci, vol.105, pp.1680-85, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-01431959
Retinoid signaling regulates breast cancer stem cell differentiation, Cell Cycle, vol.8, pp.3297-302, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01431955
Van der Wall E, Van diset PJ. Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers, Breast Cancer Res Treat, vol.123, pp.611-613, 2010. ,
ALDH1 is a marker of normal and malignant human mammary sterm cells and a predictor of poor clinical outcome, Cell Sterm Cell, vol.1, pp.555-67, 2007. ,
Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors, J Ov Research, vol.28, pp.1-13, 2010. ,
, European Journal of Histochemistry, vol.58, p.2251, 2014.
,
, Aldehyde dehydrogenase 1 positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer, Clin Cancer Res, vol.16, pp.45-55, 2010.
Distinct expression levels and atterns of sterm cell marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in human epithelial cancers, Plos One, vol.5, p.10277, 2010. ,
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells, Int J Cancer, vol.130, pp.29-39, 2012. ,
The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae, Int J Gynecol Pathol, vol.32, pp.444-53, 2013. ,
Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation, Stem cells, vol.30, pp.2487-97, 2012. ,
Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk, Int J Gynecol Cancer, vol.19, pp.65-72, 2009. ,